logo
Select company
Select metric
-1389.44%EBIT Margin
VS
Market
5
Sector
17
Industry
33
History
43
$ 3.04Close
$ 1.41 - $ 15.24 52-Week Range
Ticker Information

Ticker

VIVS

Company Name

VIVOSIM LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIVOSIM LABS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIVS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -1.97M-1389.44%$ 142K
3/31/2025$ -2.48M-1719.44%$ 144K
12/31/2024$ -12.38M-10145.9%$ 122K
9/30/2024$ -12.54M-12174.76%$ 103K
6/30/2024$ -13.98M-19157.53%$ 73K
3/31/2024$ -14.67M-13457.8%$ 109K
12/31/2023$ -19.08M-7885.54%$ 242K
9/30/2023$ -18.74M-5093.21%$ 368K
6/30/2023$ -18.07M-4060.67%$ 445K
3/31/2023$ -17.26M-4664.05%$ 370K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOSIM LABS INC's latest trailing twelve months (TTM) EBIT % stands at -5976.51%.
  • Over the past 5 years, VIVOSIM LABS INC's average EBIT % has been -5915.95%.
  • The median EBIT % for VIVOSIM LABS INC during this period was -4664.05%
  • VIVOSIM LABS INC reached its highest EBIT % over the past 5 years at -685.54%.
  • The lowest EBIT % recorded by VIVOSIM LABS INC in the same timeframe -19157.53%

VIVOSIM LABS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
AIM : AIM IMMUNOTECH INC -12858.68%SILO : SILO PHARMA INC -6782.19%GLTO : GALECTO INC -DRMA : DERMATA THERAPEUTICS INC -ADTX : ADITXT INC -250836.49%OGEN : ORAGENICS INC -HCWB : HCW BIOLOGICS INC -6270.17%SLRX : SALARIUS PHARMACEUTICALS INC -TOVX : THERIVA BIOLOGICS INC -REVB : REVELATION BIOSCIENCES INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for VIVOSIM LABS INC is calculated as follows: EBIT [ $ -17.81M ] / Revenues [ $ 298K ]
(=) EBIT % [ -5976.51% ]

VIVS - EBIT Margin, Last 5 years

-19157.53%

Minimum

Jun 30, 2024

-685.54%

Maximum

Dec 31, 2022

-5915.95%

Average

-4664.05%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%